Literature DB >> 19782379

Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.

Paulo Pereira Christo1, Márcia de Carvalho Vilela, Thales Lage Bretas, Renan Barros Domingues, Dirceu Bartolomeu Greco, José Antonio Livramento, Antonio Lucio Teixeira.   

Abstract

Chemokines are chemoattractant cytokines involved in the immune response of a wide variety of diseases. There are few studies assessing their role in opportunistic infections in HIV-infected patients. In this study, we measured CC and CXC chemokines in cerebrospinal fluid (CSF) samples obtained from 40 HIV-infected patients with or without opportunistic infections of the central nervous system (CNS). CSF samples were also analyzed for quantification of total protein, cell count and HIV-1 RNA. HIV+ patients with cryptococcal meningitis had higher levels of CCL2, CCL3, CCL5, CXCL9 and CXCL10 when compared to patients without opportunistic neurological infections. Furthermore, HIV+ patients with associated cryptococcal meningitis had higher levels of CCL3, CXCL9 and CXCL10 when compared to HIV+ patients with associated toxoplasmic encephalitis. CCL3 and CXCL9 levels were positively correlated with CSF HIV-1 RNA levels, CSF protein concentration, and CSF cell count. CXCL10 level was correlated with the CSF viral load and the CSF cell count and CCL5 level was correlated with the CSF cell count. In conclusion, the profile of chemokines in CSF of HIV patients may differ according to the modality of the presented opportunistic infection and according to other biological markers, such as viral load in CSF. These differences are probably related to different patterns of neuroinflammatory responses displayed by patients with different opportunistic neurological infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782379     DOI: 10.1016/j.jns.2009.09.002

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  High levels of divergent HIV-1 quasispecies in patients with neurological opportunistic infections in China.

Authors:  Yulin Zhang; Feili Wei; Qi Liang; Wei Ding; Luxin Qiao; Fengli Song; Lifeng Liu; Sufang Yang; Ronghua Jin; Jianhua Gu; Ning Li; Dexi Chen
Journal:  J Neurovirol       Date:  2013-07-10       Impact factor: 2.643

3.  Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.

Authors:  Christina C Chang; Saleha Omarjee; Andrew Lim; Tim Spelman; Bernadett I Gosnell; William H Carr; Julian H Elliott; Mohamed-Yunus S Moosa; Thumbi Ndung'u; Martyn A French; Sharon R Lewin
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

Review 4.  HIV-1 neuroimmunity in the era of antiretroviral therapy.

Authors:  Stephanie D Kraft-Terry; Andrew R Stothert; Shilpa Buch; Howard E Gendelman
Journal:  Neurobiol Dis       Date:  2010-01-04       Impact factor: 5.996

5.  Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.

Authors:  Valentina Zanin; Serena Delbue; Annalisa Marcuzzi; Eleonora Tavazzi; Rossella Del Savio; Sergio Crovella; Enrico Marchioni; Pasquale Ferrante; Manola Comar
Journal:  J Neurovirol       Date:  2012-05-12       Impact factor: 2.643

6.  Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy.

Authors:  Albert M Anderson; Suprateek Kundu; Bin Tang; Florin Vaida; Oluwakemi Okwuegbuna; Daniel McClernon; Mariana Cherner; Reena Deutsch; Debra Cookson; Melanie Crescini; Igor Grant; Henrik Zetterberg; Kaj Blennow; Magnus Gisslen; Ronald J Ellis; Scott L Letendre
Journal:  J Neuroimmunol       Date:  2021-01-21       Impact factor: 3.478

7.  HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors.

Authors:  Xun Liu; Ankit Shah; Mohitkumar R Gangwani; Peter S Silverstein; Mingui Fu; Anil Kumar
Journal:  Sci Rep       Date:  2014-03-24       Impact factor: 4.379

8.  Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis.

Authors:  Joseph N Jarvis; Graeme Meintjes; Tihana Bicanic; Viviana Buffa; Louise Hogan; Stephanie Mo; Gillian Tomlinson; Pascale Kropf; Mahdad Noursadeghi; Thomas S Harrison
Journal:  PLoS Pathog       Date:  2015-04-08       Impact factor: 6.823

9.  Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapy.

Authors:  Delio José Mora; Kennio Ferreira-Paim; Leonardo Eurípedes Andrade-Silva; Thatiane Bragine; Ivonete Helena Rocha; Barbara de Melo Ribeiro; Guilherme Henrique Machado; Virmondes Rodrigues Junior; David Nascimento Silva-Teixeira; Wieland Meyer; Mario León Silva-Vergara
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

10.  HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways.

Authors:  Anantha R Nookala; Ankit Shah; Richard J Noel; Anil Kumar
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.